Direct contribution to socio-economic world
AAVLife, a gene therapy company, aims at treating significant unmet medical need in rare diseases. Its program derives from the work of Hélène Puccio's team who used a gene-therapy approach to treat a mouse model developed to mimic the gene defect and cardiac symptoms of Friedreich’s Ataxia.
CASC4DE is a service and software development company treating and analyzing big data flow. CASC4DE derives from Marc-André Delsuc’s work. He developed an algorithm allowing the efficient and rapid denoising of datasets of harmonic signals.
ANAGENESIS Biotechnologies is a preclinical‐stage stem cell-based company, developing novel treatments for genetic and age-related muscle degenerative diseases. It is based on different muscle cell lineages differentiation technologies developed by Olivier Pourquié's team.
- BRCELL (formerly RINGTECH) a service and development company, focuses on innovative cellular screening. It is based on screening devices and methods developed by Daniel Riveline's team.
Two start-ups are currently under pre-incubation with SEMIA and expected to be created in 2015, as outcomes of 2 SATT Conectus Alsace maturation projects: